---
$id: https://graph.org.ai/products/commodity/51111846
$type: Product
source: UNSPSC
code: "51111846"
title: "Epitiostanol"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Epitiostanol

**UNSPSC Code**: 51111846
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic androgen and anabolic steroid with the molecular formula C19H30OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YE7586973L, chemically known as 2,3-epithioandrostan-17-ol but generally known as epitiostanol, which bears US NIH Compound Identifier 3243. European Medicines Agency schedules Epitiostanol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06572MIG. The term EPITIOSTANOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). EPITIOSTANOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule epitiostanol under HS 29372300 and SITC 54153. As of Q4 2014, EPITIOSTANOL remains the US FDA Preferred Term for this commodity. Epitiostanol bears US NLM identifiers UMLS ID C0059457 and NCI Concept Code C1089. SMILES: S1C2CC3(C4C(C5C(CC4)(C(O)CC5)C)CCC3CC12)C.

